Directory

>

Rachel Humphrey Md

avatar

Rachel Humphrey Md

Independent Board Director | HotSpot Therapeutics, Inc.

Boston, Massachusetts, United States

View contact details (it's free)

Rachel Humphrey Md

Summary

Rachel Humphrey, MD, is a distinguished pharmaceutical executive with over 18 years of experience in product development and clinical research, particularly in oncology and immuno-oncology. As the President and Founding CEO of Normunity, she has a proven track record in leading teams to successfully develop and commercialize new molecular entities, including the renowned drugs NEXAVAR and YERVOY. Rachel has held significant leadership roles at major pharmaceutical companies such as AstraZeneca and Bristol Myers Squibb, where she has been instrumental in shaping product strategies and overseeing global development programs. Her expertise spans from early-stage clinical trials to post-launch activities, and she has extensive experience in regulatory interactions and alliance management. Rachel's academic background includes a medical degree from Case Western Reserve University and a residency at Johns Hopkins University, underscoring her deep commitment to medical science. She is also known for her strategic insights and ability to foster collaborations between large and small biotech firms, contributing to advancements in cancer treatment.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Startup Experience

Rachel Humphrey Md

Work Experience

company logo

Independent Board Director at

Pyxis Oncology

August 2022 - Present

company logo

Scientific Advisory Board Member at

Grey Wolf Therapeutics

December 2021 - Present

company logo

President and Founding CEO at

Normunity

October 2021 - Present

company logo

Scientific Advisory Board Member at

HotSpot Therapeutics, Inc.

October 2021 - Present

company logo

Independent Board Director at

Sporos Bioventures

October 2021 - Present

company logo

Independent Board Director at

Xilio Therapeutics, Inc.

September 2019 - June 2022

company logo

Chief Medical Officer at

Black Diamond Therapeutics

September 2020 - September 2021

company logo

Board Director and Chief Medical Officer at

Treadwell Therapeutics, Inc.

January 2020 - May 2020

company logo

Head Of Research And Development at

TIO Bioventures

January 2020 - May 2020

company logo

SVP, Chief Medical Officer at

CytomX Therapeutics

August 2015 - September 2019

company logo

Member Board of Directors at

CytomX Therapeutics

March 2015 - August 2015

company logo

Vice President, Head of Immuno-Oncology at

Eli Lilly and Company

May 2015 - August 2015

company logo

SVP, Head of Immuno-Oncology at

AstraZeneca

November 2013 - December 2014

company logo

Chief Medical Officer at

Mirati Therapeutics

January 2012 - September 2013

company logo

Vice President, Development Lead, Immuno-oncology at

Bristol Myers Squibb

September 2004 - January 2012

company logo

Executive Director, Global Research and Development at

Bristol Myers Squibb

May 2003 - September 2004

company logo

Director, Global Clinical Leader, R & D at

Bayer

January 1997 - May 2003

Logos provided by Logo.dev

Rachel Humphrey Md

Education

The Johns Hopkins University School of Medicine, Residency

January 1989 - January 1992

Harvard University, Ba

January 1979 - January 1983

Frequently Asked Questions about Rachel Humphrey Md

What is Rachel Humphrey Md email address?

Rachel Humphrey Md's primary email address is ***************@normunity.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Rachel Humphrey Md work for?

Rachel Humphrey Md is a Independent Board Director at HotSpot Therapeutics, Inc., a company specializing in Commercial physical research.

Where Rachel Humphrey Md graduated from?

Rachel Humphrey Md holds a degree in Internal Medicine from The Johns Hopkins University School of Medicine.

How can I directly contact Rachel Humphrey Md?

To contact Rachel Humphrey Md directly, you can use the email address ***************@normunity.com. Complete contact information is available upon registration with Muraena.

Who is Rachel Humphrey Md?

Rachel Humphrey, MD, is a distinguished pharmaceutical executive with over 18 years of experience in product development and clinical research, particularly in oncology and immuno-oncology. As the President and Founding CEO of Normunity, she has a proven track record in leading teams to successfully develop and commercialize new molecular entities, including the renowned drugs NEXAVAR and YERVOY. Rachel has held significant leadership roles at major pharmaceutical companies such as AstraZeneca and Bristol Myers Squibb, where she has been instrumental in shaping product strategies and overseeing global development programs. Her expertise spans from early-stage clinical trials to post-launch activities, and she has extensive experience in regulatory interactions and alliance management. Rachel's academic background includes a medical degree from Case Western Reserve University and a residency at Johns Hopkins University, underscoring her deep commitment to medical science. She is also known for her strategic insights and ability to foster collaborations between large and small biotech firms, contributing to advancements in cancer treatment.

Rachel`s contact details

mail

***************@normunity.com

*********@pyxisoncology.com

*********@cytomx.com

Colleagues

avatar
Paul Thibodeau

Chief Business Officer

avatar
Eva Jack

Chief Operating Officer

avatar
Evan Friedman

Vice President, Development Operations

avatar
Fang Wang

Senior Vice President

avatar
Geraldine Harriman

Co-Founder and Chief Scientific Officer

avatar
Hadi Danaee

Vice President and Head, Translational Sciences and Clinical Biomarkers

avatar
David Pelissier

Vice President, Accounting and Corporate Controller

avatar
Stephan Hegge

Vice President Corporate Strategy

avatar
Joe Wahle

SVP, Head of Immunology

avatar
Brian Hamman

Executive Director, Chemical Biology

View Contact details (it's free)
Request Profile Removal